149 related articles for article (PubMed ID: 27499261)
1. Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma.
Qiao MX; Li C; Zhang AQ; Hou LL; Yang J; Hu HG
Oncol Rep; 2016 Oct; 36(4):2382-90. PubMed ID: 27499261
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.
Campillos M; García MA; Valdivieso F; Vázquez J
Nucleic Acids Res; 2003 Mar; 31(5):1571-5. PubMed ID: 12595566
[TBL] [Abstract][Full Text] [Related]
3. [VIPR1 promoter methylation promotes transcription factor AP-2
Ning S; He C; Guo Z; Zhang H; Mo Z
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):957-965. PubMed ID: 35869757
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
Li X; Zhang W; Zhou L; Yue D; Su X
Int J Clin Exp Pathol; 2015; 8(10):12455-63. PubMed ID: 26722432
[TBL] [Abstract][Full Text] [Related]
5. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CCAL promotes hepatocellular carcinoma progression by regulating AP-2α and Wnt/β-catenin pathway.
Liu Y; Yang Y; Wang T; Wang L; Wang X; Li T; Shi Y; Wang Y
Int J Biol Macromol; 2018 Apr; 109():424-434. PubMed ID: 29275200
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
8. [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells].
He JY; Liu QY; Wei L; Liu ZJ; Huang Y; Yu XQ; Li B; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):1-7. PubMed ID: 29737080
[TBL] [Abstract][Full Text] [Related]
9. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X; Leung YK; Ho SM
Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
[TBL] [Abstract][Full Text] [Related]
10. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
11. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
[TBL] [Abstract][Full Text] [Related]
12. DEK Expression is controlled by E2F and deregulated in diverse tumor types.
Carro MS; Spiga FM; Quarto M; Di Ninni V; Volorio S; Alcalay M; Müller H
Cell Cycle; 2006 Jun; 5(11):1202-7. PubMed ID: 16721057
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor specificity protein 1 (SP1) and activating protein 2alpha (AP-2alpha) regulate expression of human KCTD10 gene by binding to proximal region of promoter.
Liu R; Zhou A; Ren D; He A; Hu X; Zhang W; Yang L; Liu M; Li H; Zhou J; Xiang S; Zhang J
FEBS J; 2009 Feb; 276(4):1114-24. PubMed ID: 19154347
[TBL] [Abstract][Full Text] [Related]
14. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
Feng T; Liu Y; Li C; Li Z; Cai H
Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
[TBL] [Abstract][Full Text] [Related]
15. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
[TBL] [Abstract][Full Text] [Related]
16. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter.
Sitwala KV; Adams K; Markovitz DM
Oncogene; 2002 Dec; 21(57):8862-70. PubMed ID: 12483538
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
18. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
[TBL] [Abstract][Full Text] [Related]
19. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
20. The AP-2alpha transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene.
Choi HJ; Chung TW; Kim SJ; Cho SY; Lee YS; Lee YC; Ko JH; Kim CH
Glycobiology; 2008 May; 18(5):395-407. PubMed ID: 18316341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
